JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

B5888 Retigabine

Summary: An activator of voltage-gated potassium channel, used as an anticonvulsant agent
B5913 C7280948

Summary: Novel PRMT1 inhibitor

insoluble in H2O; insoluble in EtOH; ≥13.9 mg/mL
B6011 A-1210477
2 Citation

Target: Mcl-1

Summary: MCL-1 inhibitor

insoluble in DMSO; insoluble in H2O; insoluble in EtOH
B6023 PD-1/PD-L1 inhibitor 2

Target: PD-1/PD-L1 interaction

Summary: PD-1/PD-L1 interaction inhibitor

≥42 mg/mL
B6076 Myoseverin

Summary: microtubule-binding molecule

Soluble in DMSO
B6197 PF-CBP1 hydrochloride

Summary: CBP/p300 bromodomain inhibitor

≥52.5 mg/mL
B7836 Difopein

Summary: 14.3.3 Protein Inhibitor

Soluble to 5 mg/mL
C3069 O-Methylviridicatin

Summary: blocks activation of the HIV long terminal repeat by TNF-α

Soluble in DMSO
C3535 Piericidin A

Summary: mitochondrial complex I inhibitor

Soluble in DMSO
C5081 Bromoenol lactone

Summary: Inhibitor of myocardial cytosolic calcium-independent phospholipase A2 (iPLA2)

≤2 mg/mL